Devi SenGupta

Infectious diseases MD, COVID-19 clinical trials, HIV cure research, clinical/translational immunology, drug development. All views are my own.

[Devi SenGupta @DeviSenGupta3]

@Famosiintotti Hei

[Devi SenGupta @DeviSenGupta3]

@oknaofazsentido Witaj

[Devi SenGupta @DeviSenGupta3]

@oknaofazsentido Yā

[Devi SenGupta @DeviSenGupta3]

@oknaofazsentido Zdravstvuyte

[Devi SenGupta @DeviSenGupta3]

@dae2xx Wazup

[Devi SenGupta @DeviSenGupta3]

@oknaofazsentido Kiaora

[Devi SenGupta @DeviSenGupta3]

@oknaofazsentido Marhaba

[Devi SenGupta @DeviSenGupta3]

@billasowndar007 Privet

[Devi SenGupta @DeviSenGupta3]

It was such a pleasure to talk with @PlusLife about how we’re approaching #HIVCure earlier this summer at #AIDS2024 ! @GileadSciences

[Plus Life @pluslifemedia]

During #AIDS2024, Plus Life in partnership with Gilead Sciences produced a series of interviews. Here, @KarlJSchmid sits with @DeviSenGupta3, Exec. Director of Virology Therapeutic Area, to discuss why curing #HIV is so complex.

Enjoy Eps. 1 🎥

[Devi SenGupta @DeviSenGupta3]

Wonderful to be on panel with Australian HIV community advocates and clinicians yesterday, discussing HIV cure clinical trial engagement. #IAS2023 #hivcure @GileadSciences #innovationandinclusion

[NAPWHA — [email protected] @napwha]

Pop down to @GileadSciences & @ViiVHC booths during session breaks at #IAS2023 to catch 'Deliberate Discussions', short, digestible & community lead chats about a range of big topics that are being covered during conference sessions. Here are today's highlights! @iasociety

[Devi SenGupta @DeviSenGupta3]

Let’s go! Time for @vaccinenation in D.C. Join me and these superb panelists to discuss #HIVvaccines. #worldvaccinecongress

[Devi SenGupta @DeviSenGupta3]

It’s been an energizing day at #CROI2023 !!! Exciting data from the Gilead team and our partners as we push #HIVcure research forward.

[Gilead Sciences @GileadSciences]

New data and insights at #CROI2023 highlight our commitment to advancing scientific knowledge on potential pathways to achieve a cure for all people living with HIV. Read more: https://t.co/KIsQKX2Ylk

[Mallar Bhattacharya @MallarBhattach1]

Interested in a postdoc in lung biology? My lab is hiring a postdoctoral fellow! Find us at https://t.co/32JUwFNA1o or DM me. @UCSFMedicine @ATS_RCMB #Immunology #scRNAseq #Lung #postdocjobs #postdocposition

[Devi SenGupta @DeviSenGupta3]

Amazing work by our HIV treatment team…I have witnessed firsthand the tireless commitment of my colleagues who brought Lenacapavir across the finish line. PLWH deserve the best options across treatment, prevention and (someday) cure!

[Gilead Sciences @GileadSciences]

Today, the U.S. FDA approved our first-in-class #HIV treatment option administered twice-yearly for people with limited therapy choices. https://t.co/FHnFj2xNk9

[Devi SenGupta @DeviSenGupta3]

Congratulations to the Aelix team on this exciting publication! Paves the way for future therapeutic vaccine development.

[Parc Científic de Barcelona @PCB_UB]

#PCBCommunity | Positive results from @AELIX_Th’ therapeutic #HIVvaccine clinical study published in @NatureMedicine

@IrsiCaixa @iCERCA #ChristianBrander @BeaMothe @Fundacio_Lluita @BCNCheckpoint #AIDS @DeviSenGupta3 @GileadSciences #Vesatolimod

https://t.co/I6HiTBqFiM

[UNAIDS Global @UNAIDS]

Not to be missed!

Join @EamonnMurphy63, Hank Tomlinson, @LarkinCallaghan, @marct_01, @rixwolff and @USAmbPEPFAR for an important discussion about what #monkeypox means for people living with HIV and key populations.

More info and register 👇🏾